Skip to main content
SpringerLink
Log in

A DNA chip used to predict inflammatory bowel disease (IBD) prognosis is more cost effective than current clinical practice

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Buchanan J, Wordsworth S, Taylor J, Jewell D.Are genomic diagnostics economically viable? The case of the European Inflammatory Bowel Disease DNA chip. 7th World Congress of the International Health Economics Association: abstr. 1100, 13 Jul 2009. Available from: URL: http://ihea2009.abstractbook.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A DNA chip used to predict inflammatory bowel disease (IBD) prognosis is more cost effective than current clinical practice. Pharmacoecon. Outcomes News 584, 9 (2009). https://doi.org/10.2165/00151234-200905840-00021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905840-00021

Keywords

Search

Navigation